Sign In

Charles Andres, Ph.D, RAC

Thought Leader, Award Winning Author, Comprehensive Provider of Patent and FDA Strategies for Life Sciences Companies, Shareholder at Greenberg Traurig, LLP

Dr. Charles Andres, a Ph.D. and RAC holder, is a shareholder at Greenberg Traurig's Washington, D.C. office, specializing in patent prosecution, strategic patent counseling, and IP due diligence.

His expertise includes drug and medical device FDA regulatory counseling, invalidity and non-infringement opinions, life-cycle management, and advocacy for clients before the Supreme Court and Federal Circuit.

With a notable track record, he has secured patents and crafted patent portfolios leading to sales totaling around $4 billion. He has also been involved in drafting patents for multiple FDA approved drugs, including those listed in the Orange Book.

Among his accomplishments, Dr. Andres has defended a generic pharmaceutical manufacturer in an Actavis reverse payment inquiry and advised on various FDA-related matters such as medical devices, pharmaceuticals, and clinical trials.

Prior to his legal career, he spent a decade at Bristol-Myers Squibb as a medicinal chemist and project co-chair, receiving recognition like the Presidential Award.

Dr. Andres holds degrees from prestigious institutions including Hillsdale College, University of Virginia, and The Catholic University of America, Columbus School of Law.

His professional background also includes roles at renowned law firms and organizations like Wilson Sonsini Goodrich & Rosati and Sterne, Kessler, Goldstein & Fox P.L.L.C.

Charles Andres, Ph.D, RAC
Add to my network

Location

New Alexandria, Virginia, United States